日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analytical sensitivity of COVID-19 rapid antigen tests: A case for a robust reference standard.

COVID-19 快速抗原检测的分析灵敏度:需要可靠的参考标准

Toft Casey J, Bourquin Rebecca A, Sorenson Alanna E, Horwood Paul F, Druce Julian D, Schaeffer Patrick M

Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient

一名免疫功能低下患者在感染严重急性呼吸道冠状病毒2 (SARS-CoV-2) 72天后出现临床症状,且体内仍存在存活的病毒。

Hughes, Carly M; Gregory, Gareth P; Pierce, Anna B; Druce, Julian D; Catton, Mike; Chong, Brian; Sherry, Norelle L; Graham, Maryza; Chen, Melissa; Salvaris, Ross; Eise, Nicole; Lee, Jean Y H; McQuilten, Zoe; Crouch, Simon; Looker, Clare; Korman, Tony M; Stuart, Rhonda L

Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets

雪貂接种 INO-4800 疫苗后,501Y.V1 和 501Y.V2 SARS-CoV-2 变种的活病毒中和作用

Riddell, Shane; Goldie, Sarah; McAuley, Alexander J; Kuiper, Michael J; Durr, Peter A; Blasdell, Kim R; Tachedjian, Mary; Druce, Julian D; Smith, Trevor R F; Broderick, Kate E; Vasan, Seshadri S

Zika virus infection acquired during brief travel to Indonesia

在短暂前往印度尼西亚旅行期间感染了寨卡病毒。

Kwong, Jason C; Druce, Julian D; Leder, Karin